SCHEMBL5324019

SCHEMBL5324019

CC(C)(C)c1cc(Br)c(OCC(=O)O)cc1F

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 7/20 0.57
PKM P14618 1/20 0.54
CYP2C19 P33261 1/20 0.43
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
HSD17B10 Q99714 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
ELANE P08246 1/20 0.39
CD69 Q07108 1/20 0.39
FFAR1 O14842 1/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
PTGDR Q13258 1/20 0.37
POLB P06746 1/20 0.37
GLA P06280 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5324774 0.83 TSHR (0.48) PTGDR2CYP2C19TSHRALDH1A1GLA
SCHEMBL4576631 0.82 PKM (0.65) PTGDR2PKMALOX15TSHRHSD17B10
SCHEMBL29367635 0.81 PTGDR2 (0.49) PTGDR2PKMCYP2C19ALOX15TSHR
SCHEMBL31335940 0.77 KDM4E (0.32) PTGDR2ALDH1A1
SCHEMBL29368471 0.76 PKM (0.47) PTGDR2PKMCYP2C19ALOX15TSHR
SCHEMBL3923991 0.73 SMN1; SMN2 (0.57) PTGDR2ALOX15TSHRHSD17B10SMN1; SMN2
SCHEMBL5320268 0.73 CYP2C19 (0.68) PTGDR2PKMCYP2C19ALOX15TSHR
SCHEMBL17896565 0.73 SMN1; SMN2 (0.57) PTGDR2ALOX15TSHRHSD17B10SMN1; SMN2
SCHEMBL12478128 0.73 PTGDR2 (1.00) PTGDR2PKMCYP2C19ALOX15TSHR
SCHEMBL3384185 0.71 PKM (0.46) PTGDR2PKMCYP2C19TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007120012-A1 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2007-10-25 WO disclosed